AQP4 and glioma: In addition, both AQP1 and AQP4 showed a significant difference in expression pattern upon comparison with tumor markers/antigens in gliomas that are consensually used in clinical practice to establish degrees of malignancy and prognosis (Soldatelli et al., 2022).